Allspring Global Investments Holdings LLC increased its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 56 ...

Blue Trust Inc. reduced its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 42.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The ...

EST Becton Dickinson (BDX) committed to exploring all opportunities to execute separationMaximize Your Portfolio with Data Driven ...

EST Becton Dickinson (BDX) to separate biosciences, diagnostic solutions businessMaximize Your Portfolio with Data Driven ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for. BD beat analysts’ revenue ...

Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business Becton Dickinson plans to spin off its Biosciences and ...

In trading on Thursday, shares of Becton, Dickinson & Co (Symbol: BDX) crossed below their 200 day moving average of $233.84, changing hands as low as $232.30 per share. Becton, Dickinson & Co ...

BDX's acquisition of Edwards Lifesciences’ Critical Care product group and rising free cash flow are positive indicators for future growth. The stock's momentum is improving, but geopolitical ...

For the quarter ended December 2024, Becton Dickinson (BDX) reported revenue of $5.17 billion, up 9.8% over the same period last year. EPS came in at $3.43, compared to $2.68 in the year-ago quarter.

Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our P/E/Growth Investor model based on the published ...